Correlation Engine 2.0
Clear Search sequence regions

  • colon (1)
  • doxorubicin (3)
  • drug antitumor (1)
  • gram (1)
  • humans (1)
  • lung (1)
  • protocol (1)
  • pyridazines (3)
  • thiazoles (2)
  • thiazolidines (2)
  • Sizes of these terms reflect their relevance to your search.

    A novel and efficient protocol for the synthesis of thiazolo[4,5-c]pyridazine derivatives was developed. The approach utilizes a high pressure Q-Tube reactor to promote cyclocondensation reactions between 3-oxo-2-arylhydrazonopropanals and 4-thiazolidinones. The process has a significantly high atom economy and a broad substrate scope, as well as being applicable to gram scale syntheses. The in vitro cytotoxic activities of the synthesized thiazolo[4,5-c]pyridazine derivatives were examined utilizing a MTT colorimetric assay with doxorubicin as a reference anti-cancer drug and three human cancer cell lines including HCT-116 (colon), MCF-7 (breast) and A549 (lung). The results show that thiazolopyridazines 7c, h, k and p have high cytotoxic activity against the MCF-7 cell line with respective IC50 values of 14.34, 10.39, 15.43 and 13.60 μM. Moreover, the thiazolopyridazine derivative 7s also show promising cytotoxic activity against the HCT-116 cell line with IC50 = 6.90 μM . Observations made in this effort serve as a basis for further investigations into the design and preparation of new anti-cancer drugs.


    Hamada Mohamed Ibrahim, Haider Behbehani. The first Q-Tube based high-pressure synthesis of anti-cancer active thiazolo[4,5-c]pyridazines via the [4 + 2] cyclocondensation of 3-oxo-2-arylhydrazonopropanals with 4-thiazolidinones. Scientific reports. 2020 Apr 16;10(1):6492

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32300148

    View Full Text